Matt Outten, based in California, United States, is currently a Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio at BridgeBio. Matt Outten brings experience from previous roles at QED Therapeutics, a BridgeBio Company and Pharmacyclics. Matt Outten holds a Harvard University. With a robust skill set that includes Leadership, Co Promotions, In Line, Patient Assistance Program Creation, P&L Accountability and more. Matt Outten has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.